AZITHROMYCIN TARBIS 500 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG
Ask a doctor about a prescription for AZITHROMYCIN TARBIS 500 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG
How to use AZITHROMYCIN TARBIS 500 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG
Introduction
Package Leaflet: Information for the User
Azitromicina Tarbis 500 mg Powder for Oral Suspension in Sachet EFG
Azithromycin (dihydrate)
Read this package leaflet carefully before you start taking this medicine because it contains important information for you.
- Keep this package leaflet, you may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
- If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. See section 4.
Contents of the Package Leaflet
- What Azitromicina Tarbis 500 mg is and what it is used for
- What you need to know before you take Azitromicina Tarbis 500 mg
- How to take Azitromicina Tarbis 500 mg
- Possible side effects
- Storage of Azitromicina Tarbis 500 mg
- Contents of the pack and further information
1. What Azitromicina Tarbis 500 mg is and what it is used for
Azithromycin belongs to a group of antibiotics called macrolide antibiotics.
Antibiotics are used to treat bacterial infections and are not effective against viral infections such as the flu or the common cold. It is important that you follow the instructions regarding dosage, administration interval, and treatment duration as indicated by your doctor. Do not store or reuse this medicine. If you have any leftover antibiotic after completing treatment, return it to the pharmacy for proper disposal. Do not throw medicines down the drain or in the trash. |
It is used to treat the following infections:
- Upper and lower respiratory tract infections, such as otitis media, sinusitis, pharyngitis, bronchitis, and pneumonia.
- Skin and soft tissue infections.
- Sexually transmitted diseases.
2. What you need to know before you take Azitromicina Tarbis 500 mg
Do not take Azitromicina Tarbis:
- if you are allergic (hypersensitive) to azithromycin, to any other macrolide antibiotic, or to any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Talk to your doctor or pharmacist before taking Azitromicina Tarbis:
- If you have any severe liver disease. In this case, inform your doctor.
- If you experience diarrhea during treatment with this medicine or after completing treatment, inform your doctor.
- It is possible that, as with other antibiotics, during treatment with this medicine, a fungal overinfection may occur. If this happens, inform your doctor.
- If you experience any allergic reaction during treatment with Azitromicina Tarbis, characterized by symptoms such as itching, redness, skin rash, swelling, or difficulty breathing. If this happens, inform your doctor immediately.
Children
Azitromicina Tarbis should not be administered to children under 6 months.
Using Azitromicina Tarbis with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Azithromycin may interact with other medicines. Tell your doctor or pharmacist if you are taking any of the following medicines:
- Ergot-derived medicines (such as ergotamine, used to treat migraine).
- Ciclosporin (a medicine used in transplant patients).
- Digoxin (a medicine used to treat heart rhythm disorders).
- Colchicine (used for gout and familial Mediterranean fever)
- Antacids, cimetidine (medicines used for digestive problems). If you are taking antacids and Azitromicina Tarbis, it is recommended to avoid taking both medicines at the same time of day.
- Oral anticoagulants (medicines used to prevent blood clots).
- Nelfinavir, zidovudine (medicines for the treatment of infections caused by the human immunodeficiency virus).
- Terfenadine (a medicine used to treat allergies and hay fever).
- Rifabutin (a medicine for the treatment of pulmonary tuberculosis and non-pulmonary infections caused by mycobacteria).
Pregnancy and Breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Azitromicina Tarbis should not be used during pregnancy and breastfeeding unless the doctor considers it essential.
Driving and Using Machines
There is no evidence that Azitromicina Tarbis affects the ability to drive or use machines.
Azitromicina Tarbis contains sucrose
This medicine contains sucrose. If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
Patients with diabetes mellitus should note that this medicine contains 3.6 g of sucrose per 5 ml of reconstituted suspension.
3. How to take Azitromicina Tarbis 500 mg
Follow exactly the administration instructions of this medicine as indicated by your doctor. If you are unsure, consult your doctor or pharmacist again.
Remember to take your medicine.
Your doctor will indicate the duration of treatment with Azitromicina Tarbis. Do not stop treatment before completing the prescribed course, as there is a risk of relapse of the disease.
Azitromicina Tarbis is administered orally. Pour the contents of the sachet into a glass, add a little water, and mix well. The resulting suspension should be taken immediately.
The dose will be determined by your doctor based on your individual needs and the type of infection. To achieve optimal efficacy, follow your doctor's instructions regarding dose and treatment duration.
The recommended dose and administration frequency are:
Adults (including elderly patients): 500 mg (1 sachet) once a day for 3 consecutive days, with a total dose of 1500 mg (3 sachets).
For the treatment of sexually transmitted diseases, the dose is 1000 mg (2 sachets) taken as a single oral dose.
Children and adolescents: The dose of 500 mg of this presentation is only suitable for children and adolescents over 45 kg in weight, for whom the same dose as for adults is recommended.
For those with a lower weight, other presentations are recommended.
If you think the effect of Azitromicina Tarbis is too strong or too weak, talk to your doctor or pharmacist.
If you take more Azitromicina Tarbis than you should
Consult your doctor or pharmacist immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Azitromicina Tarbis
Do not take a double dose to make up for forgotten doses.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Most side effects observed in clinical trials were mild to moderate, reversible after discontinuation of the drug, and mainly affected the digestive system, consisting primarily of nausea, vomiting, diarrhea, or abdominal pain. Potentially serious side effects such as laryngeal edema (due to allergic reaction) or liver function alterations accompanied by yellowing of the skin occurred rarely.
In addition, during treatment with Azitromicina Tarbis, any of the following side effects may occur, which have been described for azithromycin when administered orally.
- Thrombocytopenia (decrease in platelet count) and transient episodes of mild neutropenia (decrease in white blood cell count).
- Aggressive reactions, nervousness, agitation, anxiety, dizziness/vertigo, convulsions, headache, somnolence, and hyperactivity.
- Hearing and taste alterations, and exceptionally, taste disturbance.
- Cardiac alterations.
- Digestive disorders such as anorexia, nausea, vomiting/diarrhea (rarely causing dehydration), soft stools, abdominal discomfort (pain/cramps), constipation, gas, severe diarrhea, and rarely, tongue discoloration.
- Liver and kidney function alterations (rarely severe).
- Skin reactions such as itching, rash, photosensitivity, fluid accumulation, or urticaria (hives). Exceptionally, serious skin reactions have occurred. Rarely: cutaneous eruption characterized by the rapid appearance of red skin areas dotted with small pus-filled bumps (small blisters filled with white/yellow liquid).
- Joint pain.
- Vaginal fungal infection (vaginitis).
- Fungal infections, fatigue, tingling sensation, and allergic reactions.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. You can also report side effects directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
5. Storage of Azitromicina Tarbis 500 mg
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the sachet and the carton after EXP. The expiry date is the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
6. Contents of the pack and further information
Composition of Azitromicina Tarbis 500 mg
- The active substance is azithromycin. Each sachet contains 500 mg of azithromycin (dihydrate).
- The other ingredients (excipients) are: sucrose, hydroxypropylcellulose (E-463), anhydrous trisodium phosphate, xanthan gum (E-415), cherry flavor, vanilla flavor, and banana flavor.
Appearance of the product and pack contents
Azitromicina Tarbis 500 mg is a powder for oral suspension in sachets.
Each pack contains 3 sachets.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
TARBIS FARMA, S.L.
Gran Vía Carlos III, 94
08028-BARCELONA (Spain)
Manufacturer:
KERN PHARMA, S.L.
Polígono Ind. Colón II
Venus, 72
08228 Terrassa (Barcelona)
Date of the last revision of this package leaflet: May 2018
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/
How much does AZITHROMYCIN TARBIS 500 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG cost in Spain ( 2025)?
The average price of AZITHROMYCIN TARBIS 500 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG in November, 2025 is around 5.62 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
- Country of registration
- Average pharmacy price5.62 EUR
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to AZITHROMYCIN TARBIS 500 mg ORAL SUSPENSION POWDER FOR SOLUTION EFGDosage form: ORAL SOLUTION/SUSPENSION, 200 mg azithromycin / 5 mlActive substance: azithromycinManufacturer: Arafarma Group S.A.Prescription requiredDosage form: TABLET, 500 mgActive substance: azithromycinManufacturer: Arafarma Group S.A.Prescription requiredDosage form: ORAL SOLUTION/SUSPENSION, 500 mgActive substance: azithromycinManufacturer: Arafarma Group S.A.Prescription required
Alternatives to AZITHROMYCIN TARBIS 500 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG in other countries
The best alternatives with the same active ingredient and therapeutic effect.
Alternative to AZITHROMYCIN TARBIS 500 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG in Poland
Alternative to AZITHROMYCIN TARBIS 500 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG in Ukraine
Online doctors for AZITHROMYCIN TARBIS 500 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for AZITHROMYCIN TARBIS 500 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG – subject to medical assessment and local rules.
Get updates and exclusive offers
Be the first to know about new services, marketplace updates, and subscriber-only promos.
